title: Protective effect of melatonin on reexpansion pulmonary edema in rats model.
abstract: BACKGROUND
  Rapid reexpansion of collapsed lungs leads to reexpansion pulmonary edema (RPE). We aimed to investigate the effect of melatonin in the prevention of RPE formation.
  
  
  METHODS
  We used a Wistar rat model in which the left lung was collapsed by ligating the left bronchus for 48 hours and then reexpanded and ventilated for an additional 2 hours. Thirty minutes before reexpansion, we injected melatonin (10 mg/kg) or vehicle intraperitoneally. We compared the wet/dry ratio, oxygenation index, myeloperoxidase (MPO) activity, nitric oxide (NO), malondialdehyde (MDA) and interleukin 8 (IL-8) levels in the reexpanded lungs between untreated and treated animals.
  
  
  RESULTS
  We found that the wet/dry ratio of the melatonin group was significantly lower than that of the vehicle group, and the oxygenation index was higher in the melatonin group. Compared with the control, melatonin pretreatment significantly decreased the activities of IL-8, NO, MDA levels and MPO in lung tissues. Histopathology of reexpanded lungs showed that the melatonin pretreatment group had less pulmonary edema and less inflammatory cell infiltration.
  
  
  CONCLUSIONS
  Melatonin decreases pulmonary edema and improves oxygenation after reexpansion by attenuating oxidative stress and inhibiting pro-inflammatory cytokines.
authors: Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
authors: Ming
authors: M
authors: Zhong
authors: Zhang-gang
authors: ZG
authors: Xue
authors: Jing
authors: J
authors: Cang
authors: Wei
authors: W
authors: Wu
authors: Jun-feng
authors: JF
authors: Huang
authors: Du-ming
authors: DM
authors: Zhu
mesh_terms: D000818:Animals; D016207:Cytokines / Q000378:metabolism; D016209:Interleukin-8 / Q000378:metabolism; D008168:Lung / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D008550:Melatonin / Q000627:therapeutic use*; D009569:Nitric Oxide / Q000378:metabolism; D018384:Oxidative Stress / Q000187:drug effects; D009195:Peroxidase / Q000378:metabolism; D011654:Pulmonary Edema / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar
chemical_list: D016207:Cytokines; D016209:Interleukin-8; D009569:Nitric Oxide; D008315:Malondialdehyde; D009195:Peroxidase; D008550:Melatonin